Title:
SCORPION VENOM FUSION PROTEIN HAVING IMPROVED EFFECT IN PROLIFERATING SKIN CELLS, AND COSMETIC COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR ALLEVIATING SKIN WRINKLES, IMPROVING SKIN ELASTICITY AND PREVENTING AGING
Document Type and Number:
WIPO Patent Application WO/2018/038567
Kind Code:
A1
Abstract:
The present invention relates to a scorpion venom fusion protein having an improved effect in proliferating skin cells, and a cosmetic composition containing the same as an active ingredient for alleviating skin wrinkles, improving skin elasticity, and preventing aging. The cosmetic composition of the present invention has an excellent effect in proliferating cells and has the effects of alleviating skin wrinkles and maintaining skin elasticity, and thus can be useful in the field of functional cosmetic products.
Inventors:
LEE SUN KYO (KR)
CHOI TAE WON (KR)
CHOI JONG NAM (KR)
KWON HYEONG IL (KR)
KIM TAE HYUN (KR)
JEONG TAE HWA (KR)
SHIN SUNG WOOK (KR)
ROH WOO YEON (KR)
RYU HAN BONG (KR)
LEE SEONG RAN (KR)
CHOI TAE WON (KR)
CHOI JONG NAM (KR)
KWON HYEONG IL (KR)
KIM TAE HYUN (KR)
JEONG TAE HWA (KR)
SHIN SUNG WOOK (KR)
ROH WOO YEON (KR)
RYU HAN BONG (KR)
LEE SEONG RAN (KR)
Application Number:
PCT/KR2017/009301
Publication Date:
March 01, 2018
Filing Date:
August 25, 2017
Export Citation:
Assignee:
NEXGEN BIOTECHNOLOGIES INC (KR)
International Classes:
C07K14/47; A61K8/64; A61Q19/00; A61Q19/08; C07K14/435; C12N15/62; C12N15/70; C12P21/00
Foreign References:
| KR101636851B1 | 2016-07-06 | |||
| KR20050036946A | 2005-04-20 | |||
| US20110027221A1 | 2011-02-03 | |||
| US20140335155A1 | 2014-11-13 | |||
| KR101678393B1 | 2016-12-06 |
Other References:
XU, TENGFEI ET AL.: "Identification of Two Novel Chlorotoxin Derivatives CA4 and CTX-23 with Chemotherapeutic and Anti-angiogenic Potential", SCIENTIFIC REPORTS, vol. 6, no. 19799, February 2016 (2016-02-01), pages 1 - 14, XP055467628
See also references of EP 3505532A4
See also references of EP 3505532A4
Attorney, Agent or Firm:
CHOI, Kyu Whan (KR)
Download PDF: